API Bulk Drug Manufacturing Company is Available for Sale

Mandated

API Bulk Drug Manufacturing Company is Available for Sale

Pharmaceutical Industry

24-07-2024

Listing Details : LB-14273

Asking Price	135 Crs
Turnover	49 Crs
Legal Entity	Public Limited
Category	Pharmaceutical Industry
Sub Category	API Bulk Drugs
Business Listed By	Business Owner

Contact Information

Overview

API Bulk Drug Manufacturing Company is Available for Sale in Uttar Pradesh. Established in 1999. The property spans 30,000 sqmts, with a built-up area of 228,431 sqft. It features a 750 KL reactor plant, currently operating at 30% capacity. This year's turnover is of 49 crs out of which 99% is domestic and 1% is export. The company specializes in the production of API bulk drugs, including Diclofenac Sodium IP/BP/USP with an annual capacity of 1200 MT, Diclofenac Potassium BP/USP at 200 MT per year, Aceclofenac IP/BP/USP at 800 MT annually, Paracetamol IP/BP/USP at 400 MT per year, Ibuprofen at 1200 MT annually, and Carbamazepine at 120 MT per year. The business currently has 8-10 distributors. The unit is WHO -GMP-FDA approved. The turnover in 2022-23 was Rs.135 crs. This sale presents an excellent opportunity to acquire a well-established API bulk drug manufacturing company with significant production capacities and room for growth. There is substantial potential for increasing production and expanding market reach both domestically and internationally. The company's strong portfolio of products and established distribution network make it a promising investment for those looking to enter or expand within the pharmaceutical industry.

Year of Establishment

1999

No. of Employees

125

Current Status of Business

Loss Making

Business Relocatable

Property Type

Owned

Property Value

55 Crs

Property Classification

Industrial

Describe Property

The property spans 30,000 sqmts, with a built-up area of 228,431 sqft.

Competition / Market

N.A

Products & Services

The company specializes in the production of API bulk drugs, including Diclofenac Sodium IP/BP/USP with an annual capacity of 1200 MT, Diclofenac Potassium BP/USP at 200 MT per year, Aceclofenac IP/BP/USP at 800 MT annually, Paracetamol IP/BP/USP at 400 MT per year, Ibuprofen at 1200 MT annually, and Carbamazepine at 120 MT per year.